title: Factors associated with adolescent use of doping agents: anabolic-androgenic steroids.
abstract: OBJECTIVE
  The purpose was to assess the importance of risk factors such as socio-demographics, sports activities, tobacco use, alcohol consumption, use of certain psychotropic substances and violence in the use of doping agents in adolescents.
  
  
  METHODS
  Cross-sectional survey using anonymous closed response questionnaire.
  
  
  METHODS
  Eight senior high schools in Uppsala, Sweden.
  
  
  METHODS
  A total of 2742 senior high school students; 1592 were in their first year (aged 16-17 years) and 1150 in their third (aged 18-19 years).
  
  
  RESULTS
  Multiple logistic regression analyses revealed that strength training, tobacco use, heavy alcohol consumption, truancy at least once a week and living alone were significantly independently associated in the use of doping agents. Further, the study showed that use of cannabis oil, LSD, amphetamine and opioids were related specifically to anabolic-androgenic steroid use.
  
  
  CONCLUSIONS
  Use of doping agents probably involves more than a desire to enhance appearance or sports performance and appears to have much in common with use of alcohol, tobacco and psychotropic drugs.
authors.affiliation: Department of Pharmaceutical Biosciences, Uppsala University, Sweden.
authors.forename: A M
authors.initials: AM
authors.lastname: Kindlundh
authors.forename: D G
authors.initials: DG
authors.lastname: Isacson
authors.forename: L
authors.initials: L
authors.lastname: Berglund
authors.forename: F
authors.initials: F
authors.lastname: Nyberg
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior; D000328:Adult; D045930:Anabolic Agents / Q000008:administration & dosage*; D003430:Cross-Sectional Studies; D006801:Humans; D008297:Male; D011619:Psychotropic Drugs; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000453:epidemiology*; D011795:Surveys and Questionnaires; D013548:Sweden / Q000453:epidemiology
chemical_list: D045930:Anabolic Agents; D011619:Psychotropic Drugs